122 related articles for article (PubMed ID: 23467929)
41. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
[TBL] [Abstract][Full Text] [Related]
42. Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines.
Gelsomino L; Panza S; Giordano C; Barone I; Gu G; Spina E; Catalano S; Fuqua S; Andò S
Cancer Lett; 2018 Aug; 428():12-20. PubMed ID: 29702197
[TBL] [Abstract][Full Text] [Related]
43. Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer.
Wu J; Li S; Jia W; Deng H; Chen K; Zhu L; Yu F; Su F
PLoS One; 2015; 10(7):e0133643. PubMed ID: 26218285
[TBL] [Abstract][Full Text] [Related]
44. Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.
Shi Y; Cao T; Huang H; Lian C; Yang Y; Wang Z; Ma J; Xia J
Cell Cycle; 2017; 16(24):2396-2403. PubMed ID: 28980872
[TBL] [Abstract][Full Text] [Related]
45. Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools.
Akrap N; Andersson D; Bom E; Gregersson P; Ståhlberg A; Landberg G
Stem Cell Reports; 2016 Jan; 6(1):121-36. PubMed ID: 26771357
[TBL] [Abstract][Full Text] [Related]
46. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
Spizzo R; Nicoloso MS; Lupini L; Lu Y; Fogarty J; Rossi S; Zagatti B; Fabbri M; Veronese A; Liu X; Davuluri R; Croce CM; Mills G; Negrini M; Calin GA
Cell Death Differ; 2010 Feb; 17(2):246-54. PubMed ID: 19730444
[TBL] [Abstract][Full Text] [Related]
47. The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer.
Omarjee S; Jacquemetton J; Poulard C; Rochel N; Dejaegere A; Chebaro Y; Treilleux I; Marangoni E; Corbo L; Romancer ML
Oncogene; 2017 May; 36(18):2503-2514. PubMed ID: 27941878
[TBL] [Abstract][Full Text] [Related]
48. Profiling of estrogen-regulated microRNAs in breast cancer cells.
Katchy A; Williams C
J Vis Exp; 2014 Feb; (84):e51285. PubMed ID: 24637950
[TBL] [Abstract][Full Text] [Related]
49. Global profiling of signaling networks: study of breast cancer stem cells and potential regulation.
Wang H; Huang M; Zhang DY; Zhang F
Oncologist; 2011; 16(7):966-79. PubMed ID: 21665913
[TBL] [Abstract][Full Text] [Related]
50. MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy.
Vahidian F; Mohammadi H; Ali-Hasanzadeh M; Derakhshani A; Mostaan M; Hemmatzadeh M; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3294-3306. PubMed ID: 30362508
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
[TBL] [Abstract][Full Text] [Related]
52. Tongshu capsule down-regulates the expression of estrogen receptor α and suppresses human breast cancer cell proliferation.
Du C; Li Z; Wang S; Zhou Z; Wang J; Dong J; Chen C
PLoS One; 2014; 9(8):e104261. PubMed ID: 25101695
[TBL] [Abstract][Full Text] [Related]
53. [Breast cancer stem cell research utilizing clinical specimens].
Mukohyama J; Shimono Y
Nihon Rinsho; 2015 May; 73(5):831-5. PubMed ID: 25985639
[TBL] [Abstract][Full Text] [Related]
54. Androgen receptor/let-7a signaling regulates breast tumor-initiating cells.
Zhang W; Liu X; Liu S; Qin Y; Tian X; Niu F; Liu H; Liu N; Niu Y
Oncotarget; 2018 Jan; 9(3):3690-3703. PubMed ID: 29423076
[TBL] [Abstract][Full Text] [Related]
55. The insights of Let-7 miRNAs in oncogenesis and stem cell potency.
Sun X; Liu J; Xu C; Tang SC; Ren H
J Cell Mol Med; 2016 Sep; 20(9):1779-88. PubMed ID: 27097729
[TBL] [Abstract][Full Text] [Related]
56. Possible carcinogenesis of tumor suppressor let-7.
Sun X; Fan C; Du N; Ren H
Med Hypotheses; 2013 Sep; 81(3):410-3. PubMed ID: 23790474
[TBL] [Abstract][Full Text] [Related]
57. MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells.
Xiao G; Li X; Li G; Zhang B; Xu C; Qin S; Du N; Wang J; Tang SC; Zhang J; Ren H; Chen K; Sun X
Oncotarget; 2017 Nov; 8(61):103261-103273. PubMed ID: 29262559
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA let-7: an emerging next-generation cancer therapeutic.
Barh D; Malhotra R; Ravi B; Sindhurani P
Curr Oncol; 2010 Feb; 17(1):70-80. PubMed ID: 20179807
[TBL] [Abstract][Full Text] [Related]
59. Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1.
Tvingsholm SA; Hansen MB; Clemmensen KKB; Brix DM; Rafn B; Frankel LB; Louhimo R; Moreira J; Hautaniemi S; Gromova I; Jäättelä M; Kallunki T
Oncogenesis; 2018 Feb; 7(2):14. PubMed ID: 29396433
[TBL] [Abstract][Full Text] [Related]
60. Let the Bile Flow! 1.0.
Hofmann AF
Hepatology; 2016 Oct; 64(4):1387-8. PubMed ID: 27178666
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
